# Oxurion NV

> Oxurion (Euronext Brussels: OXUR) is a Belgian company building a leading European group of contract research organisations (CROs) through buy-and-build acquisitions.

## Company

Oxurion NV is listed on Euronext Brussels under the ticker OXUR. The company acquires and integrates specialist CROs across the full clinical research value chain, from early-phase development to post-approval evidence generation.

## First Acquisition: Axiodis CRO

Oxurion holds a 72% majority stake in Axiodis SAS, a French specialist CRO with expertise in biometrics, clinical data management, and biostatistics. Axiodis operates the proprietary Exagis eCRF platform.

## Services (via Axiodis)

- Biometrics and clinical data management
- Biostatistics and statistical analysis
- Regulatory affairs support
- Clinical data management via Exagis eCRF
- Clinical research services for biotech, pharma, medtech, and academic sponsors

## Key Facts

- Listed: Euronext Brussels (OXUR)
- Headquarters: Belgium
- First acquisition: Axiodis SAS (France), 72% stake
- Strategy: Buy-and-build across European CRO landscape
- Technology: Exagis — next-generation proprietary eCRF platform

## Investor Relations

- Financial filings, shareholder information, and press releases: https://oxurion.com/investors/
- News and regulated information: https://oxurion.com/investors/news/
- Stock quote: https://oxurion.com/investors/shareholder-information/stock-quote-chart/

## Contact

- Website: https://oxurion.com
- Investor & business contact: https://oxurion.com/contact/